Development of an in vitro macrophage system to assess Penicillium marneffei growth and susceptibility to nitric oxide

Infection and Immunity

Volumn 65, Issue 1, 1997, Pages 279-284

  Cogliati, Massimo ^a   Roverselli, Annamaria ^a   Boelaert, Johan R ^b   Taramelli, Donatella ^a   Lombardi, Luciano ^c   Viviani, Maria Anna ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b General Hospital St Jan   (Belgium)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; CELL FREE SYSTEM; CULTURE MEDIUM; DRUG SENSITIVITY; ELECTRON MICROSCOPY; GROWTH INHIBITION; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PENICILLIUM MARNEFFEI; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0031024721     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.1.279-284.1997     Document Type: Article

References (23)

1. Alspaugh, J. A., and D. L. Granger. 1991. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun. 59:2241-2296.
2. Blasi, E., L. Pilzurra, M. Puliti, A. R. Chimienti, R. Mazzolla, R. Barluzzi, and F. Bistoni. 1995. Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds. Infect. Immun. 63:1806-1809.
3. Chan, Y. F., and T. C. Chow. 1190. Ultrastructural observations on Penicillium mameffei in natural human infection. Ultrastruct. Pathol. 14:439-452.
4. De Groote, M. A., and F. C. Fang. 1995. NO inhibitions: antimicrobial properties of nitric oxide. Clin. Infect. Dis. 21:S162-S165.
5. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
6. Drouhet, E. 1993. Penicilliosis due to Penicillium marneffei: a new emerging systemic mycosis in AIDS patients travelling or living in Southeast Asia. Review of 44 cases reported in HIV infected patients during the last 5 years compared to 44 cases of non AIDS patients reported over 20 years. J. Mycol. Méd. (Paris) 4:195-224.
7. Drouhet, E., P. Ravisse, P. Avé, C. de Bievre, B. Dupont, and A. Pietfroid. 1988. Étude mycologique, ultrastructurale et expérimentale sur Penicillium marneffei isolé d'une pénicilliose disséminée chez un SIDA. Bull. Soc. Fr. Mycol. Méd. 17:77-82.
8. Garrison, R. G., and K. S. Boyd. 1973. Dimorphism of Penicillium marneffei as observed by electron microscopy. Can. J. Microbiol. 19:1305-1309.
9. Granger, D. L., J. B. Hibbs, J. R. Perfect, and D. T. Durack. 1988. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J. Clin. Invest. 81:1129-1136.
10. Imwidthaya, P. 1994. Update of penicilliosis marneffei in Thailand. Mycopathol. 127:135-137.
11. Ishimine, T., K. Kawakami, A. Nakamoto, and A. Saito. 1995. Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii. Microbiol. Immunol. 39:49-58.
12. Jorens, P. G., J. R. Boelaert, V. Halloy, R. Zamora, Y. J. Schneider, and A. G. Herman. 1995. Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies. Infect. Immun. 63:4489-4494.
13. Kwon-Chung, K. J., and J. E. Bennett. 1992. Culture media and reagents, p. 825-826. In K. J. Kwon-Chung and J. E. Bennett, Medical Mycology. Lea & Febiger, Philadelphia.
14. Lane, T. E., G. C. Otero, B. A. Wu-Hsieh, and D. H. Howard. 1994. Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity. Infect. Immun. 62:1478-1479.
15. Michaliszyn, E., S. Sénéchal, P. Martel, and L. de Repentigny. 1995. Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages. Infect. Immun. 63:2075-2078.
16. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
17. Nakamura, L. T., B. A. Wu-Hsieh, and D. H. Howard. 1994. Recombinant murine gamma Interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect. Immun. 62: 680-684.
18. Peto, T. E. A., R. Bull, P. R. Millard, D. W. R. Mackenzie, C. K. Campbell, M. E. Haines, and R. G. Mitchell. 1988. Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus. J. Infect. 16:285-290.
19. Romagnoli, M. J., and W. G. Merz. 1994. Biology of Penicillium marneffei, abstr. F-91. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
20. Schoedon, G., M. Schneemann, R. Walter, N. Blau, S. Hofer, and A. Schaffner. 1995. Nitric oxide and infection: another view. Clin. Infect. Dis. 21:S152-S157.
21. Thongcharoen, P., P. Vithayasai, V. Vithayasai, K. Supparatpinyo, and S. Tansuphaswasdikul. 1992. Opportunistic infections in AIDS/HIV infected patients in Thailand. Thai AIDS J. 4:117-122.
22. Viviani, M. A., J. O. Hill, and D. M. Dixon. 1993. Penicillium marneffei: dimorphism and treatment, p. 413-422. In H. van den Bossche, F. Odds, and D. Kerridge (ed.), Dimorphic fungi in biology and medicine. Plenum Press, New York.
23. Viviani, M. A., A. M. Tortorano, G. Rizzardini, T. Quirino, L. Kaufman, A. A. Padhye, and L. Ajello. 1993. Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus. Eur. J. Epidemiol. 9:79-85.